[ back to News ]

Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on
March 16, 2009

March 9, 2009

LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29th Annual Health Care Conference on Monday, March 16, 2009 at 11:00 a.m. Eastern Time.  The conference will be held March 16-19, 2009 at The Boston Marriott Copley Place in Boston, Massachusetts.   

About Concert

Concert Pharmaceuticals is a clinical-stage biotechnology company focused on the application of deuterium chemistry to create novel small molecule drugs. Concert’s approach leverages known activity and safety of existing drugs to reduce time, risk and expense of drug research and development. The Company’s pipeline is focused on infectious disease, renal disease, cardiovascular disease, and cancer, among others. Founded in 2006, Concert has raised more than $96 million from leading venture capitalists and institutional investors. For more information on Concert Pharmaceuticals, please visit www.concertpharma.com.

CoNCERT and CoNCERT Pharmaceuticals are trademarks of Concert Pharmaceuticals, Inc.

[ back to top ]